243 related articles for article (PubMed ID: 23018457)
1. Reciprocal control of G1-phase progression is required for Th-POK/Runx3-mediated CD4/8 thymocyte cell fate decision.
Sato T; Chiba T; Ohno S; Sato C; Sugoh T; Miyashita K; Akatsuka H; Hozumi K; Okada Y; Iida Y; Akatsuka A; Agata Y; Chiba M; Kohu K; Satake M; Tanabe H; Saya H; Habu S
J Immunol; 2012 Nov; 189(9):4426-36. PubMed ID: 23018457
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Th-POK and Runx3 in T cell development in human thymoma.
Tokunaga T; Hayashi A; Kadota Y; Shiono H; Inoue M; Sawabata N; Okumura M
Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737
[TBL] [Abstract][Full Text] [Related]
3. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
[TBL] [Abstract][Full Text] [Related]
4. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development.
Setoguchi R; Tachibana M; Naoe Y; Muroi S; Akiyama K; Tezuka C; Okuda T; Taniuchi I
Science; 2008 Feb; 319(5864):822-5. PubMed ID: 18258917
[TBL] [Abstract][Full Text] [Related]
5. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.
He X; He X; Dave VP; Zhang Y; Hua X; Nicolas E; Xu W; Roe BA; Kappes DJ
Nature; 2005 Feb; 433(7028):826-33. PubMed ID: 15729333
[TBL] [Abstract][Full Text] [Related]
6. p300-mediated acetylation stabilizes the Th-inducing POK factor.
Zhang M; Zhang J; Rui J; Liu X
J Immunol; 2010 Oct; 185(7):3960-9. PubMed ID: 20810990
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.
Kohu K; Sato T; Ohno S; Hayashi K; Uchino R; Abe N; Nakazato M; Yoshida N; Kikuchi T; Iwakura Y; Inoue Y; Watanabe T; Habu S; Satake M
J Immunol; 2005 Mar; 174(5):2627-36. PubMed ID: 15728469
[TBL] [Abstract][Full Text] [Related]
8. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
[TBL] [Abstract][Full Text] [Related]
9. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis.
Woolf E; Xiao C; Fainaru O; Lotem J; Rosen D; Negreanu V; Bernstein Y; Goldenberg D; Brenner O; Berke G; Levanon D; Groner Y
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7731-6. PubMed ID: 12796513
[TBL] [Abstract][Full Text] [Related]
10. Regulation of thymocyte lineage commitment by the level of classical protein kinase C activity.
Ohoka Y; Kuwata T; Asada A; Zhao Y; Mukai M; Iwata M
J Immunol; 1997 Jun; 158(12):5707-16. PubMed ID: 9190920
[TBL] [Abstract][Full Text] [Related]
11. CCR7 expression in developing thymocytes is linked to the CD4 versus CD8 lineage decision.
Yin X; Ladi E; Chan SW; Li O; Killeen N; Kappes DJ; Robey EA
J Immunol; 2007 Dec; 179(11):7358-64. PubMed ID: 18025179
[TBL] [Abstract][Full Text] [Related]
12. Signals through CD8 or CD4 can induce commitment to the CD4 lineage in the thymus.
Bommhardt U; Cole MS; Tso JY; Zamoyska R
Eur J Immunol; 1997 May; 27(5):1152-63. PubMed ID: 9174605
[TBL] [Abstract][Full Text] [Related]
13. The network of transcription factors that underlie the CD4 versus CD8 lineage decision.
Naito T; Taniuchi I
Int Immunol; 2010 Oct; 22(10):791-6. PubMed ID: 20732858
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic interplay between ThPOK and Runx in lineage choice of thymocytes.
Egawa T; Taniuchi I
Blood Cells Mol Dis; 2009; 43(1):27-9. PubMed ID: 19375362
[TBL] [Abstract][Full Text] [Related]
15. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.
Yasutomo K; Doyle C; Miele L; Fuchs C; Germain RN
Nature; 2000 Mar; 404(6777):506-10. PubMed ID: 10761920
[TBL] [Abstract][Full Text] [Related]
16. Role of the transcription factor Th-POK in CD4:CD8 lineage commitment.
Kappes DJ; He X; He X
Immunol Rev; 2006 Feb; 209():237-52. PubMed ID: 16448546
[TBL] [Abstract][Full Text] [Related]
17. Thpok-independent repression of Runx3 by Gata3 during CD4+ T-cell differentiation in the thymus.
Xiong Y; Castro E; Yagi R; Zhu J; Lesourne R; Love PE; Feigenbaum L; Bosselut R
Eur J Immunol; 2013 Apr; 43(4):918-28. PubMed ID: 23310955
[TBL] [Abstract][Full Text] [Related]
18. CD4-CD8 lineage commitment is regulated by a silencer element at the ThPOK transcription-factor locus.
He X; Park K; Wang H; He X; Zhang Y; Hua X; Li Y; Kappes DJ
Immunity; 2008 Mar; 28(3):346-58. PubMed ID: 18342007
[TBL] [Abstract][Full Text] [Related]
19. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the expression of cKrox and Runx3, transcription regulatory factors controlling the lineage commitment of CD4+CD8+ into CD4 and CD8 thymocytes, respectively.
Gill BC; Jeon CH; Sung HN; Kim HL; Jin DW; Park JH
Toxicol Lett; 2008 Aug; 180(3):189-95. PubMed ID: 18602973
[TBL] [Abstract][Full Text] [Related]
20. GATA3 controls the expression of CD5 and the T cell receptor during CD4 T cell lineage development.
Ling KW; van Hamburg JP; de Bruijn MJ; Kurek D; Dingjan GM; Hendriks RW
Eur J Immunol; 2007 Apr; 37(4):1043-52. PubMed ID: 17357106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
